The hyperphagia and obesity in our mouse model further contrasts with findings from a tamoxifen-inducible model of Snord116 deletion, in which there was no difference in body weight and reduced food intake (when corrected for body weight) (45). Here, SNORD116 is linked to obesity disorder.